Prime Therapeutics LLC
09/29/2026 | Press release | Distributed by Public on 09/29/2026 22:32
Clinical Insights: Alzheimer’s in Focus
Prime Therapeutics' Clinical insights is your trusted resource for timely, evidence-based perspectives on emerging therapies and managed care strategy. Our Fall 2026 issue focuses on Alzheimer's disease - a neurodegenerative condition that affects more than 7.4 million Americans ages 65 and older.
Check out Clinical Insights: Alzheimer's in Focus for a comprehensive look at advances in diagnosis and treatment, emerging research and what's ahead.
Prime Therapeutics LLC published this content on September 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 30, 2026 at 04:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]